Inflammatory involvement into phototoxic reaction in erythropoietic protoporphyria (EPP) patients.

Immunol Res

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, U.O.C. Medicina Generale, Via F. Sforza 35, 20122, Milan, Italy.

Published: October 2019

AI Article Synopsis

  • The study investigates phototoxic reactions in patients with Erythropoietic Protoporphyria (EPP), focusing on factors like oxidative status, complement system activation, and mast cell response.
  • In summer, EPP patients showed significantly higher levels of complement components C3 and factor-B compared to controls, indicating a stronger immune response.
  • The findings suggest that phototoxic reactions can have systemic effects beyond the skin, highlighting the importance of understanding these responses for better clinical management and treatment options.

Article Abstract

Phototoxic reaction is a known feature of EPP at least in part triggered by the oxidative status, complement system activation, and mast cell response. The aim of this study was to verify some aspects involved in phototoxic reaction during a season. The complement system was evaluated by C3 assay, alternative pathway by factor-B, and classical pathway by C1q; oxidative status was tested with malondialdehyde (MDA) and mast cell by IL-10 assay. The serum samples were collected in winter and summer from 19 EPP patients and 13 controls. The reaction to sun exposure within each group was monitored without any invasive treatment. In summer, C3 and factor B were higher in patients than in controls (p = 0.002 and < 0.0001 respectively), while no change was detected for C1q. The oxidative stress was increased in summer in comparison with the control group (p = 0.04), and IL-10 an assay was normal in both seasons. The correlation between the C3 and factor-B in summer was significant. This study shows that the phototoxic reaction is not limited to the dermis but can also exert a systemic response, which could affect the general health of a patient. The knowledge of the pathophysiology of phototoxic reaction is essential for identifying new disease markers useful for improving clinical studies of known and future drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12026-019-09097-5DOI Listing

Publication Analysis

Top Keywords

phototoxic reaction
12
epp patients
8
oxidative status
8
complement system
8
mast cell
8
patients controls
8
inflammatory involvement
4
involvement phototoxic
4
reaction
4
reaction erythropoietic
4

Similar Publications

An In Vitro Strategy to Evaluate Ketoprofen Phototoxicity at the Molecular and Cellular Levels.

Int J Mol Sci

November 2024

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.

Article Synopsis
  • Phototoxicity, a common issue linked to many medications including over-the-counter ones, highlights the importance of testing drugs for their potential to cause harm under UV light!
  • This study focuses on the effects of ketoprofen on human skin cells, using various tests to analyze its cytotoxicity and phototoxicity under different treatment conditions!
  • Findings revealed that ketoprofen poses the highest risk of phototoxic reactions when it is directly applied to cells during UV exposure, affecting both pigmented and non-pigmented skin cells!
View Article and Find Full Text PDF

Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria.

Nat Commun

December 2024

Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.

Erythropoietic protoporphyria (EPP) is a genetic disease characterized by protoporphyrin IX-mediated painful phototoxicity. Currently, options for the management of EPP-associated phototoxicity are limited and no oral medication is available. Here, we investigated a novel therapy against EPP-associated phototoxicity by targeting the ATP-binding cassette subfamily G member 2 (ABCG2), the efflux transporter of protoporphyrin IX.

View Article and Find Full Text PDF

[Strategic Establishment of a High-throughput Photosafety Assessment System].

Yakugaku Zasshi

December 2024

Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka.

Chemical phototoxicity is elicited after exposure of skin to photosensitive chemicals, followed by exposure to sunlight. The intensity of ultraviolet light has increased due to ozone layer destruction; therefore, interest in avoidance of the phototoxicity risk of chemicals has increased in drug discovery and product development. Based on the mechanism of chemical phototoxicity, a photosafety screening strategy focusing on the photoreactivity of chemicals and skin exposure to chemicals was proposed.

View Article and Find Full Text PDF

Phototoxic reactions are among the most common skin-related adverse effects induced by drugs. It is believed that the binding of chemicals to melanin biopolymers is a significant factor influencing skin toxicity. The formation of drug-melanin complexes can lead to the accumulation of drugs or their photodegradation products in pigmented cells, potentially affecting phototoxic reactions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!